Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Aliza A. Panjwani, Joel Erblich, Tracey A. Revenson, Hoda J. Badr, Alex D. Federman & Juan P. Wisnivesky. (2023) The indirect influence of ‘invisible’ support on pulmonary function among adults with chronic obstructive pulmonary disease. Psychology, Health & Medicine 28:4, pages 831-842.
Read now
Read now
David Mannino, Michael Bogart, Guillaume Germain, Shirley P Huang, Afisi S Ismaila, François Laliberté, Young Jung, Sean D MacKnight, Marjorie A Stiegler & Mei Sheng Duh. (2022) Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 491-504.
Read now
Read now
Lei Chen, Xianqiu Chen, Canghong Zhi, Xuan Li & Yang Hu. (2022) Levalbuterol vs. albuterol for hospitalized patients with COPD in China: cost-utility and budget impact analysis. Journal of Medical Economics 25:1, pages 966-973.
Read now
Read now
Meng Li, Kun Cheng, Keisun Ku, Junlei Li, Hao Hu & Carolina Oi Lam Ung. (2021) Factors Influencing the Length of Hospital Stay Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in Macao Population: A Retrospective Study of Inpatient Health Record. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1677-1685.
Read now
Read now
Wilhelmine H Meeraus, Hana Mullerova, Céline El Baou, Marion Fahey, Edith M Hessel & William A Fahy. (2021) Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 225-244.
Read now
Read now
Paul L. Nguyen, Mohammed M. Uddin, Tanveer Mir, Amir Khalil, Neelambuj Regmi, Amina Pervaiz, Tanveer Hussain, Mohammed Amir Babu, Irfan Ullah, Pragnesh Patel, Prateek Lohia, Ghulam Saydain, Parvaiz A. Koul & Ayman O. Soubani. (2021) Trends in Incidence, and Mortality of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the United States Emergency Department (2010–2018). COPD: Journal of Chronic Obstructive Pulmonary Disease 18:5, pages 567-575.
Read now
Read now
Annie Navarro-Rolon, David de la Rosa-Carrillo, Cristina Esquinas, Marc Miravitlles, Miguel Angel Martinez-García & Pedro Almagro. (2021) Evolution and Comparative Analysis of Hospitalizations in Spain Due to COPD and Bronchiectasis between 2004 and 2015. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:2, pages 210-218.
Read now
Read now
Richard H. Stanford, Nicole M. Engel-Nitz, Timothy Bancroft & Breanna Essoi. (2020) The Identification and Cost of Acute Chronic Obstructive Pulmonary Disease Exacerbations in a United States Population Healthcare Claims Database. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:5, pages 499-508.
Read now
Read now
Gary T Ferguson, Tor Skärby, Lars H Nordenmark, Rosa Lamarca, Audrone Aksomaityte, Dan Lythgoe, Ileen Gilbert & Frank Trudo. (2020) Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3123-3134.
Read now
Read now
Lirong Liang, Yunxiao Shang, Wuxiang Xie, Julie Shi, Zhaohui Tong & Mohammad S Jalali. (2020) Trends in Hospitalization Expenditures for Acute Exacerbations of COPD in Beijing from 2009 to 2017. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1165-1175.
Read now
Read now
Lirong Liang, Changwei Li, Ye Shen, Hengmo Rong, Hang Jing & Zhaohui Tong. (2020) Long-Term Trends in Hospitalization and Outcomes in Adult Patients with Exacerbation of Chronic Obstructive Pulmonary Disease in Beijing, China, from 2008 to 2017. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1155-1164.
Read now
Read now
Trent Larson. (2019) Economic impact and chronic obstructive pulmonary disease outcomes of a comprehensive inhaler to nebulization therapy protocol implementation in a large multi-state healthcare system. Current Medical Research and Opinion 35:10, pages 1805-1817.
Read now
Read now
Stephen Milan, Praveen Bondalapati, Michael Megally, Eshan Patel, Pramil Vaghasia, Liam Gross, Elizabeth M Bachman, Puja Chadha & Jeremy A Weingarten. (2019) Positive Expiratory Pressure Therapy With And Without Oscillation And Hospital Length Of Stay For Acute Exacerbation Of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2553-2561.
Read now
Read now
Tetyana Kendzerska, Jason W Nickerson, Amy T Hsu, Andrea S Gershon, Robert Talarico, Sunita Mulpuru, Smita Pakhale & Peter Tanuseputro. (2019) End-of-life care in individuals with respiratory diseases: a population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1691-1701.
Read now
Read now
Bartolome R Celli, Maryam Navaie, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Todd P Gilmer. (2019) Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1019-1031.
Read now
Read now
Jing Zhang, Wanzhen Yao, Xuedan You, Tianyi Liu & Yuantao Liu. (2019) Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1195-1207.
Read now
Read now
Jin Hwa Song, Chang-Hoon Lee, Jin Woo Kim, Won-Yeon Lee, Ji Ye Jung, Joo Hun Park, Ki Suck Jung, Kwang Ha Yoo, Yong Bum Park & Deog Keom Kim. (2017) Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2455-2464.
Read now
Read now
Articles from other publishers (32)
Mustafa DENİZ, Zerrin ÖZÇELİK & Pınar OZGUN. (2023) Factors affecting mortality and patient outcome in patients with COPD followed in the intensive care unitYoğun bakım ünitesinde takip edilen KOAH'lı hastalarda mortalite ve hasta sonuçlarını etkileyen faktörler. Konuralp Tıp Dergisi 15:3, pages 395-402.
Crossref
Crossref
Faith S. Luyster, Monique Y. Boudreaux-Kelly & Jessica M. Bon. (2023) Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs. Respiratory Research 24:1.
Crossref
Crossref
Le Cai, Xu-Ming Wang, Lan Liu, Yi Zhao & Allison Rabkin Golden. (2023) Socioeconomic differentials of trends in the prevalence and economic burden of chronic obstructive pulmonary disease in rural southwest China. BMC Public Health 23:1.
Crossref
Crossref
Ashley Fraser & Phillippa Poole. (2022) Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2022:11.
Crossref
Crossref
Kirstyn J. Buchholz, Suzanne E. Neumueller, Nicholas J. Burgraff, Matthew R. Hodges, Lawrence Pan & Hubert V. Forster. (2022)
Chronic moderate hypercapnia suppresses ventilatory responses to acute CO
2
challenges
. Journal of Applied Physiology 133:5, pages 1106-1118.
Crossref
Crossref
Tham T LeMargrét BjarnadóttirDanya M QatoLarry MagderZafar ZafariLinda Simoni-Wastila. (2022) Prediction of treatment nonadherence among older adults with chronic obstructive pulmonary disease using Medicare real-world data. Journal of Managed Care & Specialty Pharmacy 28:6, pages 631-644.
Crossref
Crossref
Philip W Stone, Alexander Adamson, John R Hurst, C Michael Roberts & Jennifer K Quint. (2022) Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?. Thorax 77:3, pages 239-246.
Crossref
Crossref
Joanna Yilin Huang, Patrick Steele, Eli Dabscheck & Natasha Smallwood. (2022) Nasal High Flow Therapy For Symptom Management in People Receiving Palliative Care. Journal of Pain and Symptom Management 63:2, pages e237-e245.
Crossref
Crossref
Sara Wu, Maryam Alikhil, Rochelle Forsyth & Bryan Allen. (2021) Impact of Potentially Unwarranted Intravenous Antibiotics Targeting Pulmonary Infections in Acute Decompensated Heart Failure. Journal of Pharmacy Technology 37:6, pages 298-303.
Crossref
Crossref
Mikash Mohan, Ashwaghosha Parthasarathi, Chaya S K, Jayaraj Biligere Siddaiah & Padukudru A Mahesh. (2021) Fibrinogen: A Feasible Biomarker in Identifying the Severity and Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Cureus.
Crossref
Crossref
Asim Kichloo, Abdul Mannan Khan Minhas, Shakeel Jamal, Ali Tariq Shaikh, Micheal Albosta, Jagmeet Singh, Muhammad Zia Khan, Micheal Aljadah, Farah Wani, Muhammad Hisham Khan Wazir & Khalil Kanjwal. (2021) Trends and Inpatient Outcomes of Primary Heart Failure Hospitalizations with a Concurrent Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (from The National Inpatient Sample Database from 2004 to 2014). The American Journal of Cardiology 150, pages 69-76.
Crossref
Crossref
Brianna K. Kimball, Ronald A. Tutalo, Taro Minami & Charles B. Eaton. (2021) Evaluating an integrated chronic obstructive pulmonary disease management program implemented in a primary care setting. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 4:6, pages 697-710.
Crossref
Crossref
Hanadi Y. Hamadi, Dayana Martinez, Julia Palenzuela & Aaron C. Spaulding. (2021) Magnet Hospitals and 30-Day Readmission and Mortality Rates for Medicare Beneficiaries. Medical Care 59:1, pages 6-12.
Crossref
Crossref
Shinhee Park, Seung Won Ra, Sung Yoon Kang, Hwan-Cheol Kim & Sei Won Lee. (2020) Effect of particulate matter exposure on patients with COPD and risk reduction through behavioural interventions: the protocol of a prospective panel study. BMJ Open 10:11, pages e039394.
Crossref
Crossref
Swetha R. PalliMonica FrazerMary DuCharmeAmi R. BuikemaAmy J. AndersonJessica Franchino-Elder. (2020) Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy. Journal of Managed Care & Specialty Pharmacy 26:10, pages 1363-1374.
Crossref
Crossref
Ryan Dull & Stacey Dull. (2020) Redundant medication use during acute exacerbation of chronic obstructive pulmonary disease in hospitalized patients. International Journal of Clinical Pharmacy 42:5, pages 1278-1285.
Crossref
Crossref
Rajesh Kunadharaju & Sanjay Sethi. (2020) Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 41:3, pages 439-451.
Crossref
Crossref
Eric J Chow, Melissa A Rolfes, Ruth L Carrico, Stephen Furmanek, Julio A Ramirez, Jill M Ferdinands, Alicia M Fry & Manish M Patel. (2020) Vaccine Effectiveness Against Influenza-Associated Lower Respiratory Tract Infections in Hospitalized Adults, Louisville, Kentucky, 2010–2013. Open Forum Infectious Diseases 7:7.
Crossref
Crossref
Ruby Shah. 2020. Dementia and Chronic Disease. Dementia and Chronic Disease
95
109
.
Yongtao Wei, Songxia Wang, Dongping Wang & Cheng Liu. (2019) Expression and clinical significance of serum amyloid�A and interleukin‑6 in patients with acute exacerbation of chronic obstructive pulmonary disease. Experimental and Therapeutic Medicine.
Crossref
Crossref
Swetha R Palli, Ami R Buikema, Mary DuCharme, Monica Frazer, Shuchita Kaila & Timothy Juday. (2019) Costs, exacerbations and pneumonia after initiating combination tiotropium olodaterol versus triple therapy for chronic obstructive pulmonary disease. Journal of Comparative Effectiveness Research 8:15, pages 1299-1316.
Crossref
Crossref
Jessica Chen, Leanne Kaye, Michael Tuffli, Meredith A Barrett, Shelanda Jones-Ford, Tina Shenouda, Rahul Gondalia, Kelly Henderson, Veronica Combs, David Van Sickle & David A Stempel. (2019) Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis. JMIR Formative Research 3:4, pages e13286.
Crossref
Crossref
de Miguel-Diez, Jiménez-García, Hernández-Barrera, Puente-Maestu, Girón-Matute, de Miguel-Yanes, Méndez-Bailón, Villanueva-Orbaiz, Albaladejo-Vicente & López-de-Andrés. (2019) Trends in the Use and Outcomes of Mechanical Ventilation among Patients Hospitalized with Acute Exacerbations of COPD in Spain, 2001 to 2015. Journal of Clinical Medicine 8:10, pages 1621.
Crossref
Crossref
Holly J. Kramer & Sankar D. Navaneethan. (2019) CKD and Other Comorbidities. Nephrology Self-Assessment Program 18:4, pages 242-244.
Crossref
Crossref
Katherine H. Ross, Rachel E. Patzer, David Goldberg, Nicolas H. Osborne & Raymond J. Lynch. (2019) Rural‐Urban Differences in In‐Hospital Mortality Among Admissions for End‐Stage Liver Disease in the United States. Liver Transplantation 25:9, pages 1321-1332.
Crossref
Crossref
Angelo G. Corsico, Fulvio Braido, Marco Contoli, Fabiano Di Marco, Paola Rogliani, Carla Scognamillo, Irene Olivi, Pierachille Santus, Nicola Scichilone & Carlo Lazzaro. (2019) Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up. Respiratory Medicine 153, pages 68-75.
Crossref
Crossref
Ashley Fraser & Phillippa Poole. (2019) Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Maochun Wu, Zequan Wang, Manman Li & Kun Li. (2017) Daily Symptom Variability in Patients With Stable COPD: A Narrative Review. Western Journal of Nursing Research 40:10, pages 1543-1561.
Crossref
Crossref
Antonio Anzueto & Marc Miravitlles. (2018) Chronic Obstructive Pulmonary Disease Exacerbations: A Need for Action. The American Journal of Medicine 131:9, pages 15-22.
Crossref
Crossref
Shruti K. Gadre, Abhijit Duggal, Eduardo Mireles-Cabodevila, Sudhir Krishnan, Xiao-Feng Wang, Katrina Zell & Jorge Guzman. (2018) Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease (COPD). Medicine 97:17, pages e0487.
Crossref
Crossref
Xinyi Jiang, Hong Xiao, Richard Segal, William Cary Mobley & Haesuk Park. (2018) Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014. Clinical Therapeutics 40:4, pages 613-626.e1.
Crossref
Crossref
Fasiha Kanwal, Aylin Tansel, Jennifer R Kramer, Hua Feng, Steven M Asch & Hashem B El-Serag. (2017) Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013. American Journal of Gastroenterology 112:8, pages 1287-1297.
Crossref
Crossref